RxDoctor Payments DataLook up a doctor →

Youssef Josephson, DO

Interventional Pain Medicine · West Deptford, NJNPI 1598928608

Payments from drug & device makers

$581,913in general payments, 2019–2025

Across 2,080 payments — averaging $279.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$173K
  • Boston Scientific$121K
  • Vertiflex, Inc.$98K
  • Medtronic$89K
  • SPR Therapeutics, Inc$33K
  • Painteq LLC$22K
  • plus $45K from 50 others
$855in research payments, 2019–2025

Across 3 payments — averaging $285.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Painteq LLC$625
  • Medtronic$230

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott705$172,929
Boston Scientific233$121,169
Vertiflex, Inc.126$98,432
Medtronic(2 entities)184$89,232
SPR Therapeutics, Inc6$32,797
Painteq LLC107$22,357
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC81$8,373
Tersera Therapeutics LLC41$7,397
Nalu Medical, Inc.22$6,677
Aurora Spine, Inc.3$5,280
Vertos Medical, Inc.39$4,557
Foundation Fusion Solutions, LLC13$3,866
Relievant Medsystems, Inc.38$2,565
Biodelivery Sciences International, Inc.74$761
Collegium Pharmaceutical, Inc.58$718
Nevro Corp.29$569
Globus Medical24$458
Amgen59$453
Zyla Life Sciences, Inc.54$427
Pfizer27$301
Si-bone, Inc.13$269
Stimwave Technologies Incorporated3$224
MDD US Operations, LLC23$220
Daiichi Sankyo Inc.26$204
USWM, LLC18$140
Spinal Simplicity, LLC1$133
Novo Nordisk1$110
Biotronik NRO, Inc.3$106
Bioventus LLC3$98
Arbor Pharmaceuticals, Inc.6$84
Saluda Medical Americas, Inc.2$76
IBSA Pharma Inc.5$73
Scilex Pharmaceuticals Inc.5$69
Takeda Pharmaceuticals U.S.A., Inc.11$68
Protega Pharmaceutials Inc4$65
Flowonix Medical Incorporated1$61
AstraZeneca(2 entities)4$57
Avanos Medical3$52
GRT US Holding, Inc.4$51
Brixton Biosciences, Inc.1$48
Johnson & Johnson2$47
Axonics, Inc.2$41
MML US, Inc.1$36
International Rehabilitative Sciences, Inc1$35
Azurity Pharmaceuticals, Inc.2$34
Forte Bio-pharma LLC2$33
Fidia Pharma USA Inc.1$25
Stryker1$23
Almatica Pharma LLC1$17
Shionogi Inc1$15
Averitas Pharma Inc.1$15
Currax Pharmaceuticals LLC1$14
Teva Pharmaceuticals USA, Inc.1$14
Cumberland Pharmaceuticals, Inc.1$13
Kowa Pharmaceuticals America, Inc.1$13
Redhill Biopharma Inc.1$12

How this compares

$581,913 in reported general payments places this provider in the 95th percentile of 82 interventional pain medicine providers in New Jersey.

See all interventional pain medicine providers in New Jersey

Medicare billing

Part B allowed, 2024
$448,687
Medicare patients
494
Services billed
5,464

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional pain medicine in West Deptford

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →